Careers  |  Sign In  |  Register

Latest in Medical Students

Reuters Health • The Doctor's Channel Daily Newscast

Ticagrelor Pharmacogentetics

NEW YORK (Reuters Health) – While clopidogrel’s effectiveness in the treatment of acute coronary syndromes is affected by a patient’s genotype, the efficacy of ticagrelor is not. Therefore, ticagrelor eliminates the need for genetic testing recommended before dual antiplatelet therapy, a multicenter...

Reuters Health • The Doctor's Channel Daily Newscast

Sodium and Urinary Stone Formation

NEW YORK (Reuters Health) - Despite some recent contradictory findings, South Korean investigators conclude that a sodium-restricted diet is important in reducing the risk of recurrence in patients prone to develop urinary stones. Dr. Sang-Cheol Lee and colleagues at Chungbuk National University in...

Reuters Health • The Doctor's Channel Daily Newscast

Clopidogrel and Concurrent PPI Use

NEW YORK (Reuters Health) - Patients starting on clopidogrel are almost twice as likely to have an MI over the next few months if they are taking a proton pump inhibitor as those not on a PPI, according to a large Dutch cohort study. While the results are in line with other reports, the association may...